
Genopore
Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.
About
Genopore is developing the world's first digital protein identification and quantification system. Their technology uses direct optical detection at the single-molecule level to provide unparalleled insights into the proteome, enabling whole-protein identification without mass spectrometry or affinity-based methods. This system serves researchers in areas like disease mechanism and early detection, precision medicine, and biomarker discovery.
Similar companies
AI-driven digital twin of embryo development for cell-based therapies.
Shares Life Sciences, Biotech
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Life Sciences, Biotech
AI-driven platform for protein-level disease mapping and drug discovery.
Shares Life Sciences, Drug Discovery
Computational platform using LLMs trained on biological and chemical data for drug discovery.
Shares Life Sciences, Drug Discovery
Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.
Shares Life Sciences, Biotech
Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.
Shares Life Sciences, Genomics
Key facts
At-a-glance profile data
- Website
- genopore.com
- Headquarters
- San Diego, United States
- Founded
- 2022
- Employees
- 50
- Total funding
- -
- Business model
- B2B
Tech stack
Detected on genopore.com, last scanned 16 Oct 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Frequently asked
How many employees does Genopore have?
Genopore has approximately 50 people on record.